ABO and cancer: ABO may also be associated with cancer risk as the A antigen can be detected in tumor cells from non-A individuals, while glycosylation can lead to conformational changes in proteins such as the epidermal growth factor receptor or alter immune recognition of natural killer cells, conditions that favor tumorigenesis [12].